RT Journal Article
SR Electronic
T1 A new Far-UVC based method for germ free hospitals and travel: Initus-V
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.23.21255969
DO 10.1101/2021.04.23.21255969
A1 Ayhan Olcay
A1 Serdar Baki Albayrak
A1 İbrahim Faruk Aktürk
A1 Mehmet Cengiz Akbülbül
A1 Onur Yolay
A1 Hande İkitimur
A1 Mehmet Çetin Bayer
YR 2021
UL http://medrxiv.org/content/early/2021/04/27/2021.04.23.21255969.abstract
AB Direct contact and airborne spread are main mechanisms of transmission for SARS-CoV-2, and virus can stay viable for at least 3 hours in aerosols. Initus-V system uses a Far-ultraviolet C (UVC) system, UVC resistant textile and googles to provide virus, bacteria and spore free environments in hospitals, crowded public places and travel environments. Initus-V system may help in prevention of epidemic diseases such as Coronavirus disease-19 (Covid-19), influenza, treatment of airborne viral diseases and spread of hospital-borne resistant infections.Competing Interest StatementInitus-V system was developed by InnowayRG Inc and Vestel Home appliances Inc. A patent application has been made to TURKPATENT in the partnership of these two companies. (TR 2020/07546) Ayhan Olcay, Serdar Baki Albayrak, Onur Yolay are founders of InnowayRG Inc. Mehmet Cengiz Akbulbul and Mehmet Cetin Bayer are inventors Hande İkitimur and Mehmet Faruk Akturk report no conflicts of interest. Funding StatementInitus-V system was developed by InnowayRG Inc and Vestel Home appliances Inc. A patent application has been made to TURKPATENT in the partnership of these two companies. (TR 2020/07546) Ayhan Olcay, Serdar Baki Albayrak, Onur Yolay are founders of InnowayRG Inc. Mehmet Cengiz Akbulbul and Mehmet Cetin Bayer are inventors Hande İkitimur and Mehmet Faruk Akturk report no conflicts of interest. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical committee of Ataturk University, Erzurum, Turkey has approved studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll referred data is available